ArticleHypertension research : official journal of the Japanese Society of Hypertension2026
Change in incidence of patients with peripartum cardiomyopathy.
Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertensive disorders of pregnancy (HDP) are associated with some patients with peripartum cardiomyopathy (PPCM). However, no studies have reported changes in the incidence of PPCM before and after the introduction of calcium channel blockers (CCBs) for HDP treatment in Japan. Thirteen patients (aged 25-43 years; mean age, 33 years) with PPCM from two hospitals in Nagasaki Prefecture were included. PPCM was defined as idiopathic cardiomyopathy that occurs in late pregnancy or the months following delivery, without other causes of heart failure and with a left ventricular ejection fraction <45%. We compared the incidence of PPCM between the nine years from January 2003 to December 2011 (prior to CCB initiation) and the nine years from January 2012 to December 2020 (after CCB initiation). The incidence of PPCM has decreased after CCB initiation compared to prior to CCB initiation (0.36/year, 1/1520 births vs. 1 patient/year, 1/610 births). Treatment with HDP, including CCB, may prevent the development of PPCM in Japan.
Indexed as
Identifiers
41272123What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.